1. Genomics and Chlamydial Persistence
- Author
-
Steven J. Carrell, Robert J. Suchland, and Dan D. Rockey
- Subjects
Serotype ,Models, Molecular ,Sexually Transmitted Diseases, Bacterial ,Protein Conformation ,sexually transmitted diseases ,Chlamydia trachomatis ,Biology ,medicine.disease_cause ,Microbiology ,Host-Microbe Biology ,trpA ,03 medical and health sciences ,In vivo ,Virology ,Operon ,medicine ,Tryptophan Synthase ,Humans ,Amino Acid Sequence ,Chlamydia ,Frameshift Mutation ,Letter to the Editor ,Phylogeny ,030304 developmental biology ,Sequence Deletion ,Author Reply ,0303 health sciences ,Mutation ,Base Sequence ,030306 microbiology ,Strain (biology) ,persistence ,Gene Expression Regulation, Bacterial ,Genomics ,Chlamydia Infections ,medicine.disease ,Phenotype ,In vitro ,QR1-502 ,interferon gamma ,indole - Abstract
We read with interest the recent paper by Somboonna and colleagues, addressing changes to tryptophan synthase in a single Chlamydia trachomatis strain that had an aberrant growth phenotype in vitro (1). This strain was isolated four times, over 4 years, from a patient who was apparently persistently infected. This strain was highly related to a serovar F strain isolated previously in their clinical setting. The authors use these strains to defend an association between in vivo persistence and a particular mutation at the 3′ end of the …
- Published
- 2019